Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.molimm.2009.01.019
Title: Genome-scale search of tumor-specific antigens by collective analysis of mutations, expressions and T-cell recognition
Authors: Jia, J.
Cui, J.
Liu, X.
Han, J. 
Yang, S.
Wei, Y.
Chen, Y.
Keywords: Cancer vaccines
Human cancer genomes
Tumor-specific antigens
Issue Date: May-2009
Citation: Jia, J., Cui, J., Liu, X., Han, J., Yang, S., Wei, Y., Chen, Y. (2009-05). Genome-scale search of tumor-specific antigens by collective analysis of mutations, expressions and T-cell recognition. Molecular Immunology 46 (8-9) : 1824-1829. ScholarBank@NUS Repository. https://doi.org/10.1016/j.molimm.2009.01.019
Abstract: Background: Tumor-specific antigens (TSAs) are potential sources of cancer vaccines, some of which are derived from T-cell epitopes of over-expressed mutant proteins to elicit immunogenicity and overcome tolerance and evasion. The lack of effective vaccines for many cancers has prompted strong interest in improved TSA search methods. Recent progresses in profiling somatic mutations and expressions of human cancer genomes, and in predicting T-cell epitopes enable genome-scale TSA search by collectively analyzing these profiles. Such a collective approach has not been explored in spite of the availability and usage of individual methods. Methodology: Genome-scale TSA search was conducted by genome-scale search of tumor-specific mutations in differentially over-expressed genes of specific cancers based on tumor-specific somatic mutation and microarray gene expression data, followed by T-cell recognition analysis of the identified mutant and over-expressed peptides to determine if they are substrates of proteasomal cleavage, TAP mediated transport and MHC-I alleles capable of eliciting immune response. The performance of our method was tested against 12 and 4 known T-cell defined melanoma and lung cancer TSAs in the Cancer Immunity database. Conclusions: Our approach identified 50% and 75% of the 12 and 4 known TSAs and predicted from the human cancer genomes additional 8-250 and 14-359 putative TSAs of 5 and 3 HLA alleles respectively. The known TSA hit rates (1.9% and 0.8%) are enriched by 29-fold and 35-fold over those of mutation analysis. The numbers of predicted TSAs are within the testing range of typical screening campaigns. Noises in expression data of small sample sizes appear to be a major factor for misidentification of known TSAs. With improved data quality and analysis methods, the collective approach is potentially useful for facilitating genome-scale TSA search. © 2009 Elsevier Ltd.
Source Title: Molecular Immunology
URI: http://scholarbank.nus.edu.sg/handle/10635/100755
ISSN: 01615890
DOI: 10.1016/j.molimm.2009.01.019
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

4
checked on Sep 20, 2019

WEB OF SCIENCETM
Citations

4
checked on Sep 12, 2019

Page view(s)

47
checked on Sep 7, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.